1.3m switched to new ARV, but weight gain is a concern

1.3m switched to new ARV, but weight gain is a concern

Two years after it was announced that the ARV dolutegravir would become part of standard first line HIV treatment in South Africa, it is finally reaching significant numbers of people. But new research about a worrying side-effect, weight gain (particularly in women), has muddied its otherwise stellar reputation.

Read More

COVID-19: Social distancing includes reducing contact with health facilities for those with chronic conditions

COVID-19: Social distancing includes reducing contact with health facilities for those with chronic conditions

People living with HIV and other chronic conditions should be urgently supported to reduce contact with health facilities both for “social distancing” purposes as well as saving healthcare worker capacity for those with the greatest immediate need, argues Lynne Wilkinson and Anna Grimsrud.

Read More